APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,923 | -57.8% | 76,865 | +1.1% | 0.00% | -66.7% |
| Q2 2023 | $6,924 | +2977.3% | 76,011 | +2120.6% | 0.01% | – |
| Q1 2023 | $225 | -100.0% | 3,423 | -88.4% | 0.00% | -100.0% |
| Q3 2022 | $2,023,000 | +340.7% | 29,627 | +191.5% | 0.00% | – |
| Q2 2022 | $459,000 | +206.0% | 10,164 | +242.6% | 0.00% | – |
| Q1 2022 | $150,000 | – | 2,967 | +103.8% | 0.00% | – |
| Q4 2020 | $0 | – | 1,456 | -65.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 4,264 | -5.8% | 0.00% | – |
| Q2 2020 | $147,000 | -7.5% | 4,525 | -24.0% | 0.00% | – |
| Q1 2020 | $159,000 | +169.5% | 5,954 | +139.2% | 0.00% | – |
| Q3 2019 | $59,000 | +5800.0% | 2,489 | +3218.7% | 0.00% | – |
| Q2 2019 | $1,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |